Spanish Red Biotech Pipeline

MSD

Pembrolizumab/Lenvatinib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Lenvatinib plus Pembrolizumab in Previously Treated Subjects with Selected Solid Tumors
Phase: 2Phase II in Spain, 1Phase I